Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SOX2 overlapping transcript, exon 4 (SOX2OT_exon4) is a segment of a long non-coding RNA overlapping the SOX2 protein-coding locus. This transcript is not a classical receptor, enzyme, transporter, or gene product targeted by drugs; rather, it is part of a non-coding region thought to be involved in gene regulation at the RNA level, possibly influencing the expression of developmental regulators such as SOX2[1][5]. There is no established role as a therapeutic drug target, no recognized involvement in major disease pathways for this specific exon, and no known direct modulators or biomarkers. This ID is likely not appropriate for drug-target mapping.\n\nKey limitations: ENSG00000278026 is strictly a non-coding RNA transcript, not a protein, receptor, or pharmacological target[1][5]. No canonical drugs, safety concerns, or established mechanism-of-action exist. May be incorrectly included in therapeutic target mapping. If you need structured information for pharmacological targets, the SOX2 gene (SRY-box transcription factor 2, ENSG00000181449) is a protein-coding gene and actual drug/disorder target, distinct from SOX2OT_exon4[7][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SOX2 overlapping transcript, exon 4 (SOX2OT_exon4).